Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020

SELL
$53.85 - $65.27 $2.43 Million - $2.95 Million
-45,197 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$59.06 - $72.15 $535,378 - $654,039
9,065 Added 25.09%
45,197 $2.71 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $495,291 - $687,138
7,977 Added 28.33%
36,132 $2.32 Million
Q1 2019

May 16, 2019

SELL
$52.92 - $81.17 $183,050 - $280,767
-3,459 Reduced 10.94%
28,155 $2.29 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $1.37 Million - $1.88 Million
31,614 New
31,614 $1.71 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.